Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 237 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2778 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Actual shortage | 2024-05-03 | 2024-05-03 | 227082 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Actual shortage | 2024-05-03 | 2024-05-03 | 227085 |
| APO-CYCLOBENZAPRINE | 10MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-03 | 227091 |
| APO-QUETIAPINE FUMARATE | 200MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-05-08 | 216705 |
| APO-PREGABALIN | 25MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-08 | 216732 |
| APO-PREGABALIN | 75MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-08 | 216741 |
| APO-TERAZOSIN | 2MG | TABLET | Resolved | 2024-04-26 | 2024-05-10 | 226330 |
| APO-TERAZOSIN | 10MG | TABLET | Resolved | 2023-06-16 | 2024-05-10 | 195259 |
| APO-TERAZOSIN | 5MG | TABLET | Resolved | 2024-04-12 | 2024-05-10 | 224999 |
| APO-BRIMONIDINE-TIMOP | 0.5% 0.2% | SOLUTION | Resolved | 2024-05-03 | 2024-05-10 | 227028 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Actual shortage | 2024-04-19 | 2024-05-10 | 225796 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2024-04-26 | 2024-05-10 | 226327 |
| APO-METHYLPHENIDATE | 5MG | TABLET | Resolved | 2024-03-08 | 2024-05-10 | 221723 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2024-04-12 | 2024-05-10 | 224980 |
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2024-03-08 | 2024-05-10 | 221729 |
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2024-04-19 | 2024-05-10 | 225790 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Actual shortage | 2024-01-19 | 2024-05-10 | 216669 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Actual shortage | 2024-02-16 | 2024-05-10 | 219843 |
| APO-TERBINAFINE | 250MG | TABLET | Actual shortage | 2024-04-12 | 2024-05-10 | 225005 |
| APO-DASATINIB | 70MG | TABLET | Actual shortage | 2024-04-19 | 2024-05-10 | 225776 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
| APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
| APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |
| APO-DIPYRIDAMOLE | 50MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101891 |
| APO-DIPYRIDAMOLE | 25MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101888 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |